-
News | 2023.11.14
Discovery of peritumoral stromal cells that regulate antitumor immunity
A team from the Institut Pasteur has discovered a new population of cells that develops around a tumor mass. This discovery opens up a new avenue of treatment for solid tumors. This offers hope for improving the treatment of cancers for which immunotherapies are often ineffective, such as pancreatic, breast and prostate cancer.
-
Document de presse | 2023.10.19
Genes fuelling antibiotic resistance in Yemen cholera outbreak uncovered
An international collaborative research effort involving scientists from the Wellcome Sanger Institute, the University of Toronto, the Institut Pasteur and Sana'a University has revealed the source of antibiotic resistance that emerged in bacteria driving the cholera outbreak that is currently affecting Yemen. The results of their research, published on September 28, 2023 in the journal Nature...
-
Document de presse | 2023.11.14
Significant "post-COVID" resurgence in invasive meningococcal disease
A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by...
-
News | 2023.11.15
The history of the first rabies vaccination in 1885
In 1885, a boy by the name of Joseph Meister was bitten 14 times by a rabid dog, with life-threatening consequences. Dr. Jacques Joseph Grancher convinced Louis Pasteur and his colleagues to vaccinate the young man. This first human rabies vaccination was a resounding success.
-
News | 2023.11.15
The Institut Pasteur pays tribute to Dr. Grancher, physician and “Pasteurian”
On November 7, 2023, the Grancher Foundation celebrated its 120th anniversary on the Institut Pasteur campus. The Foundation was established by Dr. Joseph Grancher. It was an opportunity for the Institut Pasteur's President to pay tribute to the physician best known for his work on tuberculosis – a disease that the Institut Pasteur continues to fight.
-
News | 2023.11.16
Antibiotic resistance, or how bacteria become resistant
Antibiotic resistance is a major public health issue. Understanding how resistance works and how bacteria become resistant is crucial in helping us maintain the effectiveness of antibiotics against bacteria.
-
News | 2023.11.24
The Institut Pasteur & Kyoto University have signed a LOI to establish the Pasteur Aging Research Center
Professor Stewart Cole, President of the Institut Pasteur and Professor Nagahiro Minato, President of the Kyoto University signed a Letter of Intent (LOI) to create the Pasteur Aging Research Center (“PARC”) in Japan. This Letter of Intent is yet another step on the path to the creation of the Institut Pasteur of Japan (IPJ), as the PARC will become one of the research centers of the Institut...
-
News | 2023.11.27
The spin-off Oncovita wins the France 2030 call for projects
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030 investment plan. The company will receive €4.5 million in funding from Bpifrance to support the development of its immunotherapeutic cancer vaccine, MVdeltaC. The company will also benefit from €3.5 million in private funding. This...
-
Vidéo | 2023.11.28
All about HIV/AIDS with Michaela Müller-Trutwin
Although there have been considerable advances in treatment, HIV continues to be a serious problem, especially in the terminal phase of the disease in the absence of treatment, known as AIDS. HIV/AIDS is currently one of the leading causes of death worldwide for adolescents and women of childbearing age.Michaela Müller-Trutwin, Head of HIV, Inflammation and Persistence Unit (Institut Pasteur...
-
Document de presse | 2023.11.14
Odette Tomescu-Hatto appointed Institut Pasteur Executive Vice-President, International Affairs
Dr. Odette Tomescu-Hatto has been appointed Executive Vice-President, International Affairs at the Institut Pasteur, with effect from January 2024.Following the meeting of the Board of Governors on October 11, 2023, Dr. Odette Tomescu-Hatto was appointed Executive Vice-President, International Affairs at the Institut Pasteur, with effect from January 2024.Dr. Odette Tomescu-Hatto holds a PhD in...
